Dr. Agarwal's Health Care Seeks Shareholder Approval for New Statutory Auditor

1 min read     Updated on 17 Nov 2025, 03:02 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Dr. Agarwal's Health Care Limited initiates postal ballot for appointing M/s. S.R. Batliboi & Associates LLP as new statutory auditors, replacing Deloitte Haskins & Sells. This change aligns with pre-merger activities involving subsidiary Dr. Agarwal's Eye Hospital Limited. E-voting period set from November 18 to December 17, with proposed auditor fee of ₹52.50 lakh for the upcoming financial year. The move aims to streamline audit processes across the group post-merger.

24917569

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care Limited has initiated a postal ballot process to seek shareholder approval for the appointment of a new statutory auditor. This move comes as part of the company's pre-merger alignment activities with its subsidiary, Dr. Agarwal's Eye Hospital Limited (AEHL).

Key Points of the Postal Ballot

  • New Auditor Proposed: M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, is proposed to replace M/s. Deloitte Haskins & Sells.
  • Reason for Change: The change is part of pre-merger activities to align the statutory audit function across the group.
  • E-voting Period: From November 18 to December 17.
  • Proposed Auditor Fee: ₹52.50 lakh for the upcoming financial year.

Background and Rationale

The Board of Directors of Dr. Agarwal's Health Care and its material subsidiary AEHL approved a merger on August 27. Following this, AEHL appointed M/s. S.R. Batliboi & Associates LLP as their Statutory Auditors on September 24.

Dr. Agarwal's Health Care is now seeking to appoint the same audit firm to promote synergy, uniformity, and operational efficiency in audit processes across the group. This alignment is expected to streamline audit and reporting practices for the combined entity post-merger.

Resignation of Current Auditor

M/s. Deloitte Haskins & Sells have resigned effective November 12 to facilitate this change. The company stated that the outgoing auditors have not raised any concerns, and the resignation is solely to enable the appointment of AEHL's existing statutory auditors.

Proposed Auditor Details

M/s. S.R. Batliboi & Associates LLP, if approved, will serve as the Statutory Auditors until the conclusion of the 16th Annual General Meeting of the company. The firm, established in 1949, is part of S.R. Batliboi & Affiliates network and has offices across key Indian cities.

Voting Process

Shareholders can cast their votes electronically through the e-voting system provided by KFin Technologies Limited. The e-voting period is set from 9:00 AM IST on November 18 to 5:00 PM IST on December 17.

This move by Dr. Agarwal's Health Care Limited represents a significant step in their merger process and aims to enhance the efficiency of their audit procedures across the group structure.

Historical Stock Returns for Dr. Agarwal's Health Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.34%-0.82%-5.89%+24.18%+24.97%+24.97%
Dr. Agarwal's Health Care
View in Depthredirect
like16
dislike

Dr. Agarwal's Health Care Announces Change in Statutory Auditors

1 min read     Updated on 13 Nov 2025, 04:05 AM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Dr. Agarwal's Health Care Limited's Board has approved S.R. Batliboi & Associates LLP as new statutory auditors, replacing Deloitte Haskins & Sells. The change, effective November 12, 2025, aims to align auditors with the company's listed material subsidiary as part of an ongoing merger process. The appointment is subject to shareholder approval via postal ballot. S.R. Batliboi & Associates LLP will hold office until the conclusion of the 16th Annual General Meeting.

24532550

*this image is generated using AI for illustrative purposes only.

Dr. Agarwal's Health Care Limited, a prominent player in the healthcare sector, has announced a significant change in its statutory auditors. The company's Board of Directors has approved the appointment of S.R. Batliboi & Associates LLP as the new statutory auditors, replacing Deloitte Haskins & Sells.

Key Highlights of the Auditor Change

  • Resignation of Current Auditors: Deloitte Haskins & Sells has stepped down as the statutory auditors of Dr. Agarwal's Health Care Limited and its material subsidiary, Dr. Thind Eye Care Private Limited, effective November 12, 2025.

  • Reason for Change: The resignation is part of an effort to align auditors with the company's listed material subsidiary, Dr. Agarwal's Eye Hospital Limited, as part of an ongoing merger process.

  • New Auditor Appointment: S.R. Batliboi & Associates LLP has been appointed to fill the casual vacancy, subject to shareholder approval through postal ballot.

  • Term of New Auditors: The new auditors will hold office until the conclusion of the 16th Annual General Meeting.

Details of the Auditor Transition

Aspect Outgoing Auditor Incoming Auditor
Firm Name Deloitte Haskins & Sells S.R. Batliboi & Associates LLP
Registration No. 008072S 101049W/E300004
Effective Date of Change November 12, 2025 November 12, 2025
Reason for Change Stepping down to facilitate alignment with subsidiary's auditors Appointed to fill casual vacancy

Impact and Implications

The change in auditors is a strategic move aimed at streamlining audit and reporting practices for the combined entity post-merger. Deloitte Haskins & Sells has confirmed that no concerns or issues were raised during their tenure, emphasizing that the transition is purely for operational efficiency.

S.R. Batliboi & Associates LLP, part of the S.R. Batliboi & Affiliates network, brings extensive experience in auditing large listed and private companies across diverse market segments. Their appointment is expected to provide continuity and expertise in financial reporting as Dr. Agarwal's Health Care Limited moves forward with its corporate restructuring plans.

Shareholder Approval Process

The appointment of S.R. Batliboi & Associates LLP is subject to shareholder approval, which will be sought through a postal ballot. Shareholders on record as of November 14, 2025, will be eligible to participate in this voting process.

This change in statutory auditors marks a significant corporate action for Dr. Agarwal's Health Care Limited, aligning its audit processes with its strategic objectives and ongoing corporate restructuring efforts.

Historical Stock Returns for Dr. Agarwal's Health Care

1 Day5 Days1 Month6 Months1 Year5 Years
+0.34%-0.82%-5.89%+24.18%+24.97%+24.97%
Dr. Agarwal's Health Care
View in Depthredirect
like20
dislike
More News on Dr. Agarwal's Health Care
Explore Other Articles
501.95
+1.70
(+0.34%)